Evidence map›Paper›PMID 32214050›Full record

ReviewInternational journal of molecular sciences2020

The Respiratory Phenotype of Pompe Disease Mouse Models.

Anna F Fusco, Angela L McCall, Justin S Dhindsa, Lucy Zheng, Aidan Bailey, Amanda F Kahn, Mai K ElMallah

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. What's new and what's next for gene therapy in Pompe disease?Expert opinion on biological therapy · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. GAA deficiency disrupts distal airway cells in Pompe disease.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  6. Pathophysiology of Lysosomes in a Nutshell.International journal of molecular sciences · 2023
    Article
  7. [Research progress of nervous system damage in Pompe disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Review
  8. Review
  9. Induced pluripotent stem cell for modeling Pompe disease.Frontiers in cardiovascular medicine · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna F FuscoDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.ORCID 0000-0003-4245-8290
Angela L McCallDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.ORCID 0000-0001-5249-7176
Justin S DhindsaDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.
Lucy ZhengDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.
Aidan BaileyDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.
Amanda F KahnDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.
Mai K ElMallahDepartment of Pediatrics, School of Medicine, Duke University, Durham, NC 27707, USA.ORCID 0000-0002-1775-1156
Duke University · US

Funding

Targeted Therapy for Pompe DiseaseR01HD099486 · NICHD · DUKE UNIVERSITY · PI ELMALLAH, MAI · 2019 to 2023
$1.7M
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD099486NICHD NIH HHS R01 HD099486
6 · The paper itself

Abstract

Pompe disease is a glycogen storage disease caused by a deficiency in acid α-glucosidase (GAA), a hydrolase necessary for the degradation of lysosomal glycogen. This deficiency in GAA results in muscle and neuronal glycogen accumulation, which causes respiratory insufficiency. Pompe disease mouse models provide a means of assessing respiratory pathology and are important for pre-clinical studies of novel therapies that aim to treat respiratory dysfunction and improve quality of life. This review aims to compile and summarize existing manuscripts that characterize the respiratory phenotype of Pompe mouse models. Manuscripts included in this review were selected utilizing specific search terms and exclusion criteria. Analysis of these findings demonstrate that Pompe disease mouse models have respiratory physiological defects as well as pathologies in the diaphragm, tongue, higher-order respiratory control centers, phrenic and hypoglossal motor nuclei, phrenic and hypoglossal nerves, neuromuscular junctions, and airway smooth muscle. Overall, the culmination of these pathologies contributes to severe respiratory dysfunction, underscoring the importance of characterizing the respiratory phenotype while developing effective therapies for patients.

Indexed as

Disease Models, AnimalPhenotypeRespirationAnimalsGlycogen Storage Disease Type IIMicebreathingpompe diseaserespiratory

Identifiers

PMID32214050
PMCPMC7139647
OpenAlexW3002519511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.